Pharma Company

  • Cabinet clears KKR investments in two pharma companies May 13, 2014

    The government on cleared private equity major KKR's proposal to acquire stakes in two pharmaceutical companies in deals worth over Rs 1,400 crore, including 38 per cent stake buy in Gland Pharma. The two deals are estimated to be worth Rs 1,434 crore, sources said. In the first proposal, the Cabinet...
  • SC to hear PIL on the pricing of drugs in India August 5, 2013

    New Delhi: The Supreme Court on Monday will hear a PIL by the pharma companies on the pricing of medicines in India. The PIL was filed by four pharma firms who challenged the Delhi High Court's order to reduce the prices of certain medicines. These pharma companies were also asked to...
  • Ranbaxy fined $ 500 mn for selling adulterated drugs May 14, 2013

    New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and...
  • Investments in India by global pharma cos to continue: Vikas Dandekar April 1, 2013

    In a landmark verdict, the Supreme Court dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving the way for more affordable lifesaving cancer drugs. How does it affect the Indian pharmaceutical industry and the global biggies who are looking...
  • Will now invest in India 'cautiously', says Novartis April 1, 2013

    Mumbai: Pharmaceutical giant Novartis on Monday termed the Supreme Court's judgement of not granting a patent to its cancer drug Glivec as "disappointing" and warned that though it will continue to introduce new products in India, it will now invest "cautiously". In a landmark verdict, the apex court dismissed the...
  • 'SC ruling discourages innovative drug discovery' April 1, 2013

    New Delhi: Swiss pharmaceutical company Novartis, which lost its battle for patent on its cancer drug Glivec in India on Monday, said the Supreme Court's ruling discourages innovative drug discovery and is a setback for patients. "Novartis has never been granted an original patent for Glivec in India. We strongly believe...
  • Novartis stock down 4.5 per cent after SC verdict April 1, 2013

    Mumbai: Shares of the Swiss pharmaceutical giant Novartis fell about 4.5 per cent on Monday after the Supreme Court of India dismissed its plea for a patent on its cancer drug, Gelvic. Shares of select Indian pharmaceutical companies rallied as the industry is set to receive a boost following the...
  • Yusuf Hamied's message on being CNNIBN's IOTY in business category December 17, 2012

    Dr. Yusuf K Hamied of Cipla Limited was awarded the CNNIBN Indian of The Year 2012 in the business category. He was awarded for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries. Here's Dr Hamid's message after being awarded...
  • India rejects Abbot lab's patent application January 3, 2011

    Mumbai: India has rejected a drug patent application of a US multinational pharma company, paving way for easy access to an important lifesaving medication for HIV patients across the globe. The decision to reject the patent application on the important combination drug, Lopinavir/Ritonavir filed by Abbot Laboratories was given by the...
  • No gifts for docs from pharma companies: Govt February 17, 2010

    The relation between the doctor and the drug companies is under the scanner again. This time the law wants to punish a pharma company if they try to lure doctors. The Medical Council of India has ordered to cancel licenses of the firms. ...
  • EU alarmed over India's clout in global drug market January 30, 2010

    New Delhi: India's growing clout in the global drug business is making the European Union see red. The EU is now blocking India's drug exports to African and Latin American countries. Exclusive details available with CNNIBN shows the European Union has been detaining and seizing Indian consignments that pass through the...
  • WHO exaggerated H1N1 to benefit pharma cos? January 13, 2010

    New Delhi: Was the swine flu scare exaggerated to benefit pharma companies? Evidence has surfaced that several members of the World Health Organisation's (WHO) vaccine board which pushed countries to buy the H1N1 vaccine have had significant ties with pharma companies. Documents acquired through the Danish Freedom of...
  • Forbes India: How Lupin kept its health, healed its past December 2, 2009

    Call it luck or design. But in the gallery of large Indian drug makers, Desh Bandhu Gupta is among the last men still holding their heads high. A tumultuous year has taken a toll on most domestic names. Companies had either bitten off more than they could chew by making...
  • India pharma cos turning global September 20, 2006

    Mumbai: With nearly 5 per cent share in the world generic market, are Indian pharma companies ready to go global? How competitive are their current business models? Shahina Mukadam of IDBI Capital Markets says that acquisitions done by the pharma companies will start delivering from next year. She adds...
  • US firm buys Matrix Labs for $736 mn August 28, 2006

    Mumbai: In the largest ever cross border deal in India, Mylan Labs of US have picked up a 71.5 per cent stake in Hyderabadbased Matrix Labs for $736 million. US based Mylan will also takeover debts up to $200 million from Matrix, which will mount up the total deal value...